| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/26/2003 | CA2421012A1 Designing and construction of transcription template for cell-free protein synthesis, and dilution batch wheat embryo cell-free protein synthesis method using the same |
| 02/25/2003 | US6525190 Amidase |
| 02/25/2003 | US6525188 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling |
| 02/25/2003 | US6525180 Antibodies to mammalian T cell surface antigen |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525178 PGC-1, a novel brown fat PPARgamma coactivator |
| 02/25/2003 | US6524825 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/25/2003 | US6524823 Vasopermeability-enhancing conjugates |
| 02/25/2003 | US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia |
| 02/25/2003 | US6524817 DNA encoding a receptor subunit for oncostatin M |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524802 Methods of detecting growth differentiation factor-14 |
| 02/25/2003 | US6524799 DNA encoding sparc-related proteins |
| 02/25/2003 | US6524796 Selecting proteins that binds to said promoter DNA; introducing DNA coding for said proteins into cells carrying a reporter gene; testing for presence of said reporter gene expression product |
| 02/25/2003 | US6524588 Influenza vaccine |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
| 02/25/2003 | CA2048910C Antimicrobial peptides active against plant pathogens, their method of use and various screening methods pertaining thereto |
| 02/25/2003 | CA2039718C Chimeric dna-rna catalytic sequences |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014371A1 Method for preparing ester linked peptide-carbohydrate conjugates |
| 02/20/2003 | WO2003014361A1 Novel recombinant gene expression method by stop codon suppression |
| 02/20/2003 | WO2003014360A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | WO2003014339A2 Carbohydrates and polyols for dissolving protein crystals |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014162A1 ANTIBODY RECOGNIZING GM1 GANGLIOSIDE-BOUND AMYLOID β-PROTEIN AND DNA ENCODING THE ANTIBODY |
| 02/20/2003 | WO2003014161A2 Antigen binding domains from fish |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014149A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 02/20/2003 | WO2003014147A1 Novel depsipeptides and process for preparing same |
| 02/20/2003 | WO2003014142A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | WO2003013602A1 Inhibitors of her3 activity |
| 02/20/2003 | WO2002098369A3 Mutant forms of cholera holotoxin as an adjuvant |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002092758A8 Gastrokines and derived peptides including inhibitors |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene |
| 02/20/2003 | WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase |
| 02/20/2003 | WO2002058637A3 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002047730A8 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | US20030037346 Protein production system |
| 02/20/2003 | US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies |
| 02/20/2003 | US20030036643 Methods and compositions for the construction and use of fusion libraries |
| 02/20/2003 | US20030036637 Purification of human serum albumin |
| 02/20/2003 | US20030036635 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects |
| 02/20/2003 | US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics |
| 02/20/2003 | US20030036507 Urocortin-III and uses thereof |
| 02/20/2003 | US20030036505 Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon |
| 02/20/2003 | US20030036181 Peptide extended glycosylated polypeptides |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036174 Hair follicle growth factor proteins |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036116 Can be used in combination with other mutagenesis methods |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders |
| 02/20/2003 | US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders |
| 02/20/2003 | US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035811 Method of inactivating microorganisms |
| 02/20/2003 | US20030035800 Glycosylated humanized B-cell specific antibodies |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | US20030035796 Novel compound for treatment of allergy and asthma |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2763913A1 Antigen binding domains |
| 02/20/2003 | CA2456882A1 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof |
| 02/20/2003 | CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | CA2456761A1 Novel depsipeptides and process for preparing same |
| 02/20/2003 | CA2456723A1 Inhibitors of her3 activity |
| 02/20/2003 | CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof |